ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
3.510
-0.080 (-2.23%)
Nov 17, 2026, 9:30 AM EST - Market open

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $37.71M in the quarter ending September 30, 2026, with 16.03% growth. This brings the company's total for the last twelve months to $122.14M, down -14.45% year-over-year. In the year 2025, ARS Pharmaceuticals had annual revenue of $84.28M, down -5.46%. That makes ARS Pharmaceuticals the 21,230th largest company in the world by revenue and 3,167th in the United States.

Revenue (ttm)
$122.14M
Revenue Growth
-14.45%
P/S Ratio
2.95
Revenue / Employee
$592,893
Employees
206
Market Cap
352.85M

Revenue Chart

Revenue by Geography

  • United States 72.19M 85.7%
  • Rest of World 12.09M 14.3%
Fiscal year ended Dec 31, 2025 See the full ARS Pharmaceuticals breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202584.28M-4.87M-5.46%
Dec 31, 202489.15M89.12M297,063.33%
Dec 31, 202330.00K-1.29M-97.72%
Dec 31, 20221.32M-4.19M-76.10%
Dec 31, 20215.51M-12.33M-69.13%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CorMedix412.49M
Puma Biotechnology231.83M
Alector173.47M
Fennec Pharmaceuticals66.37M
Opus Genetics7.91M
SL Science Holding3.27M
Revenue Rankings